Live Breaking News & Updates on Olefi

Stay informed with the latest breaking news from Olefi on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Olefi and stay connected to the pulse of your community

Kaizer Chiefs appoint Molefi Ntseki in key role at Naturena

Former Bafana Bafana coach Molefi Ntseki has joined Kaizer Chiefs as the club's Head of Technical and Youth Development Academy.The

South-africa , South-african , Kaizer-motaung , Gavin-hunt , Bafana , Molefi-ntseki , Youth-development-academy , Former-bafana , Kaizer-chiefs , Youth-development , Africa-news , Olefi-ntseki

SAFA deny that Molefi Ntseki is Bafana Bafana's assistant coach

SAFA deny that Molefi Ntseki is Bafana Bafana's assistant coach
News24
15 May 2021, 08:10 GMT+10
Molefi Ntseki was the subject of a bizarre turn of events on Friday after he was named by
Bafana Bafana head coach
Hugo Broos as part of a new-look technical team, a claim that has since been denied by
SAFA.
The Belgian named his predecessor Ntseki - who SAFA recently sacked - as his assistant during an interview on the Sport On with Thabiso Mosia show on SAfm.
SAFA released a statement that contradicted their own head coach by dismissing earlier reports while insisting a local assistant coach was yet to be finalised.

South-africa , Zimbabwe , Macedonia , Belgium , Cameroon , Macedonian , South-african , Belgian , Hugo-broos , Thabiso-mosia , Bafana , Molefi-ntseki

Celyad Oncology SA: Celyad: Transparency Notification Received From Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

(0)
Regulatory News:
Celyad Oncology SA (Euronext Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that it has received a transparency notification from Tolefi SA, dated 3 May 2021.
Tolefi SA has notified that its 2.295.701 shares benefit from a double voting right as of May 3, 2021 and that its shareholding has crossed above the threshold of 25%. The full transparency notice is available on the Celyad website under the heading "Regulated Information".
About Celyad Oncology SA
Celyad Oncology SA is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized) CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium and New York, NY. The Company has received funding from the Walloon Region (Belgium) to support the advancement of its CAR T cell therapy programs. For more information, please visit www.celyad.com.

Mont-saint-guibert , Waals-gewest , Belgium , New-york , United-states , Walloon-region , Paris , France-general , France , Brussels , Bruxelles-capitale , Sara-zelkovic